Galapagos NV: GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS

14:41 EDT 20 May 2018 | FinanzNachrichten

Mechelen, Belgium; 20 May 2018; 20.30 CET; Galapagos NV (Euronext & NASDAQ: GLPG) announces publication milestones on GLPG1690 in idiopathic pulmonary fibrosis (IPF). In addition to presenting thr...

More From BioPortfolio on "Galapagos NV: GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS"